CATTRINI, CARLO
CATTRINI, CARLO
100007 - Dipartimento di Medicina interna e specialità mediche
A hnRNP K–AR-related signature reflects progression toward castration-resistant prostate cancer
2018-01-01 Capaia, MATTEO GINO LINO; Granata, Ilaria; Guarracino, Mario; Petretto, Andrea; Inglese, Elvira; Cattrini, Carlo; Ferrari, Nicoletta; Boccardo, Francesco; Barboro, Paola
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer
2019-01-01 Cattrini, C; Zanardi, E; Rubagotti, A; Zinoli, L; Capaia, M; Barboro, P; Boccardo, F.
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes
2017-01-01 Boccardo, F; Cavo, A; Zanardi, E; Fabbroni, C; Zinoli, L; Di Meglio, A; Arboscello, E; Bellodi, A; Spallarossa, P; Cattrini, C; Messina, C; Rubagotti, A
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes
2018-01-01 Cavo, Alessia; Rubagotti, Alessandra; Zanardi, Elisa; Fabbroni, Chiara; Zinoli, Linda; Di Meglio, Antonio; Arboscello, Eleonora; Bellodi, Andrea; Spallarossa, Paolo; Cattrini, Carlo; Messina, Carlo; Boccardo, Francesco
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer
2018-01-01 Cattrini, Carlo; Zanardi, Elisa; Boccardo, Francesco
Atezolizumab and bladder cancer: facing a complex disease
2018-01-01 Cattrini, Carlo; Boccardo, Francesco
Bone metastases from prostate cancer: hormonal therapy
2017-01-01 Zanardi, Elisa; Cattrini, Carlo; Boccardo, Francesco
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications
2020-01-01 Messina, Carlo; Cattrini, Carlo; Soldato, Davide; Vallome, Giacomo; Caffo, Orazio; Castro, Elena; Olmos, David; Boccardo, Francesco; Zanardi, Elisa
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
2018-01-01 Messina, Carlo; Cattrini, Carlo; Buzzatti, Giulia; Cerbone, Luigi; Zanardi, Elisa; Messina, Marco; Boccardo, Francesco
Combination therapy in metastatic renal cell carcinoma: Back to the future?
2020-01-01 Cerbone, Luigi; Cattrini, Carlo; Vallome, Giacomo; Latocca, Maria Maddalena; Boccardo, Francesco; Zanardi, Elisa
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
2019-01-01 Cattrini, Carlo; Castro, Elena; Lozano, Rebeca; Zanardi, Elisa; Rubagotti, Alessandra; Boccardo, Francesco; Olmos, David
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS
2018-01-01 Messina, C; Messina, M; Cattrini, C; Cerbone, L; Mastrocinque, G; Zanardi, E; Spatafora, P
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
2020-01-01 Cattrini, Carlo; Soldato, Davide; Rubagotti, Alessandra; Zinoli, Linda; Zanardi, Elisa; Barboro, Paola; Messina, Carlo; Castro, Elena; Olmos, David; Boccardo, Francesco
Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study
2020-01-01 Cattrini, C.; Capaia, M.; Boccardo, F.; Barboro, P.
Genitourinary tumours in the targeted therapies era: New advances in clinical practice and future perspectives
2016-01-01 Messina, Carlo; Buzzatti, Giulia; Dellepiane, Chiara; Cavo, Alessia; Tolomeo, Francesco; Cattrini, Carlo; Boccardo, Francesco
Immunotherapy for genitourinary cancer: State of the art and new perspectives
2016-01-01 Cattrini, Carlo; Dellepiane, Chiara; Cavo, Alessia; Buzzatti, Giulia; Tolomeo, Francesco; Messina, Carlo; Boccardo, Francesco
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer
2020-01-01 Cattrini, Carlo; Barboro, Paola; Rubagotti, Alessandra; Zinoli, Linda; Zanardi, Elisa; Capaia, MATTEO GINO LINO; Boccardo, Francesco
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study
2018-01-01 Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Buzzatti, Giulia; Vallome, Giacomo; Rizzo, Fabio; Cavo, Alessia; Beshiri, Kristi; Soldato, Davide; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study
2019-01-01 Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco
Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States
2020-01-01 Cattrini, C; Zanardi, E; Rubagotti, A; Zinoli, Ld; Capaia, M; Barboro, P; Boccardo, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A hnRNP K–AR-related signature reflects progression toward castration-resistant prostate cancer | 1-gen-2018 | Capaia, MATTEO GINO LINO; Granata, Ilaria; Guarracino, Mario; Petretto, Andrea; Inglese, Elvira; Cattrini, Carlo; Ferrari, Nicoletta; Boccardo, Francesco; Barboro, Paola | |
| A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer | 1-gen-2019 | Cattrini, C; Zanardi, E; Rubagotti, A; Zinoli, L; Capaia, M; Barboro, P; Boccardo, F. | |
| Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes | 1-gen-2017 | Boccardo, F; Cavo, A; Zanardi, E; Fabbroni, C; Zinoli, L; Di Meglio, A; Arboscello, E; Bellodi, A; Spallarossa, P; Cattrini, C; Messina, C; Rubagotti, A | |
| Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes | 1-gen-2018 | Cavo, Alessia; Rubagotti, Alessandra; Zanardi, Elisa; Fabbroni, Chiara; Zinoli, Linda; Di Meglio, Antonio; Arboscello, Eleonora; Bellodi, Andrea; Spallarossa, Paolo; Cattrini, Carlo; Messina, Carlo; Boccardo, Francesco | |
| Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer | 1-gen-2018 | Cattrini, Carlo; Zanardi, Elisa; Boccardo, Francesco | |
| Atezolizumab and bladder cancer: facing a complex disease | 1-gen-2018 | Cattrini, Carlo; Boccardo, Francesco | |
| Bone metastases from prostate cancer: hormonal therapy | 1-gen-2017 | Zanardi, Elisa; Cattrini, Carlo; Boccardo, Francesco | |
| BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications | 1-gen-2020 | Messina, Carlo; Cattrini, Carlo; Soldato, Davide; Vallome, Giacomo; Caffo, Orazio; Castro, Elena; Olmos, David; Boccardo, Francesco; Zanardi, Elisa | |
| CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials | 1-gen-2018 | Messina, Carlo; Cattrini, Carlo; Buzzatti, Giulia; Cerbone, Luigi; Zanardi, Elisa; Messina, Marco; Boccardo, Francesco | |
| Combination therapy in metastatic renal cell carcinoma: Back to the future? | 1-gen-2020 | Cerbone, Luigi; Cattrini, Carlo; Vallome, Giacomo; Latocca, Maria Maddalena; Boccardo, Francesco; Zanardi, Elisa | |
| Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer | 1-gen-2019 | Cattrini, Carlo; Castro, Elena; Lozano, Rebeca; Zanardi, Elisa; Rubagotti, Alessandra; Boccardo, Francesco; Olmos, David | |
| EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS | 1-gen-2018 | Messina, C; Messina, M; Cattrini, C; Cerbone, L; Mastrocinque, G; Zanardi, E; Spatafora, P | |
| Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer | 1-gen-2020 | Cattrini, Carlo; Soldato, Davide; Rubagotti, Alessandra; Zinoli, Linda; Zanardi, Elisa; Barboro, Paola; Messina, Carlo; Castro, Elena; Olmos, David; Boccardo, Francesco | |
| Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study | 1-gen-2020 | Cattrini, C.; Capaia, M.; Boccardo, F.; Barboro, P. | |
| Genitourinary tumours in the targeted therapies era: New advances in clinical practice and future perspectives | 1-gen-2016 | Messina, Carlo; Buzzatti, Giulia; Dellepiane, Chiara; Cavo, Alessia; Tolomeo, Francesco; Cattrini, Carlo; Boccardo, Francesco | |
| Immunotherapy for genitourinary cancer: State of the art and new perspectives | 1-gen-2016 | Cattrini, Carlo; Dellepiane, Chiara; Cavo, Alessia; Buzzatti, Giulia; Tolomeo, Francesco; Messina, Carlo; Boccardo, Francesco | |
| Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer | 1-gen-2020 | Cattrini, Carlo; Barboro, Paola; Rubagotti, Alessandra; Zinoli, Linda; Zanardi, Elisa; Capaia, MATTEO GINO LINO; Boccardo, Francesco | |
| Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study | 1-gen-2018 | Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Buzzatti, Giulia; Vallome, Giacomo; Rizzo, Fabio; Cavo, Alessia; Beshiri, Kristi; Soldato, Davide; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco | |
| Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study | 1-gen-2019 | Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco | |
| Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States | 1-gen-2020 | Cattrini, C; Zanardi, E; Rubagotti, A; Zinoli, Ld; Capaia, M; Barboro, P; Boccardo, F |